Growth during Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial.

被引：0
|
作者：
Bharucha, Kamal N. [1 ]
Brunner, Hermine I. [2 ]
Ruperto, Nicola [3 ]
Cabral, David A. [2 ]
Gedalia, Abraham [2 ]
Gerloni, Valeria [3 ]
Jorgensen, Christian [3 ]
Ramanan, Athimalaipet [3 ]
Lovell, Daniel [2 ]
Martini, Alberto [4 ]
Frane, James
Wells, Chris [5 ]
De Benedetti, Fabrizio, Sr. [6 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] PRCSG, Cincinnati, OH USA
[3] PRINTO, Genoa, Italy
[4] Ist Giannina Gaslini, I-16148 Genoa, Italy
[5] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[6] Osped Pediat Bambino Gesu, IRCCS, Div Rheumatol, Rome, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
276
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [31] Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Results From the TENDER Trial
    Malattia, Clara
    Ruperto, Nicolino
    Palmisani, Elena
    Pederzoli, Silvia
    Pistorio, Angela
    Brunner, Hermine
    Cuttica, Ruben J.
    Calvo, Inmaculada
    Garay, Stella Maris
    Eleftheriou, Despina
    Wouters, Carine
    Wang, Jianmei
    Devlin, Clare
    Lovell, Daniel J.
    Martini, Alberto
    De Benedetti, Fabrizio
    Ravelli, Angelo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S96 - S97
  • [32] ASSESSMENT OF RADIOGRAPHIC PROGRESSION IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB: 2-YEAR RESULTS FROM THE TENDER TRIAL
    Ravelli, Angelo
    Malattia, Clara
    Ruperto, Nicola
    Palmisani, Elena
    Pederzoli, Silvia
    Pistorio, Angela
    Brunner, Hermine I.
    Cuttica, Ruben
    Penades, Inmaculada Calvo
    Garay, Stella M.
    Eleftheriou, Despina
    Wouters, Carine
    Wang, Jianmei
    Devlin, Clare
    Lovell, Daniel J.
    Martini, Alberto
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2014, 53 : 167 - 168
  • [33] Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
    Clara Malattia
    Nicolino Ruperto
    Silvia Pederzoli
    Elena Palmisani
    Angela Pistorio
    Carine Wouters
    Pavla Dolezalova
    Berit Flato
    Stella Garay
    Gabriella Giancane
    Chris Wells
    Wendy Douglass
    Hermine I. Brunner
    Fabrizio De Benedetti
    Angelo Ravelli
    [J]. Arthritis Research & Therapy, 22
  • [34] Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials
    Malattia, Clara
    Ruperto, Nicolino
    Pederzoli, Silvia
    Palmisani, Elena
    Pistorio, Angela
    Wouters, Carine
    Dolezalova, Pavla
    Flato, Berit
    Garay, Stella
    Giancane, Gabriella
    Wells, Chris
    Douglass, Wendy
    Brunner, Hermine I.
    De Benedetti, Fabrizio
    Ravelli, Angelo
    [J]. ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [35] Associations Between the American College of Rheumatology Pediatric Response Measures and the Continuous Measures of Disease Activity Used in Adult Rheumatoid Arthritis A Secondary Analysis of Clinical Trial Data From Children With Polyarticular-Course Juvenile Idiopathic Arthritis
    Ringold, Sarah
    Chon, Yun
    Singer, Nora G.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (12): : 3776 - 3783
  • [36] Tocilizumab Is Efficacious in Patients with Systemic Juvenile Idiopathic Arthritis Across Baseline Demographic and Disease Characteristics and Prior/Baseline Treatments: 52-Week Data From a Phase 3 Clinical Trial.
    De Benedetti, Fabrizio
    Brunner, Hermine
    Allen, Roger
    Brown, Diane
    Chaitow, Jeffrey
    Pardeo, Manuela
    Espada, Graciela
    Flato, Berit
    Horneff, Gerd
    Devlin, Clare
    Kenwright, Andrew
    Schneider, Rayfel
    Woo, Patricia
    Martini, Alberto
    Lovell, Daniel
    Ruperto, Nicola
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1029 - S1030
  • [37] Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial
    Nicola Ruperto
    Daniel Lovell
    Pierre Quartier
    Angelo Ravelli
    Mahinda Karunaratne
    Jasmina Kalabic
    Anabela Cardoso
    Alberto Martini
    Gerd Horneff
    [J]. Pediatric Rheumatology, 12 (Suppl 1)
  • [38] TREATING TO TARGET OF MINIMAL DISEASE ACTIVITY AND NORMAL FUNCTION IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS WITH ADALIMUMAB: ANALYSIS FROM A PHASE 3 CLINICAL TRIAL
    Ruperto, N.
    Lovell, D.
    Quartier, P.
    Ravelli, A.
    Karunaratne, M.
    Kalabic, J.
    Cardoso, A.
    Martini, A.
    Horneff, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 130 - 131
  • [39] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
    Violetta Opoka-Winiarska
    Zbigniew Żuber
    Ekaterina Alexeeva
    Vyacheslav Chasnyk
    Irina Nikishina
    Grażyna Dębowska
    Elżbieta Smolewska
    [J]. Clinical Rheumatology, 2018, 37 : 1807 - 1816
  • [40] Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial
    Opoka-Winiarska, Violetta
    Zuber, Zbigniew
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Nikishina, Irina
    Debowska, Grazyna
    Smolewska, Elzbieta
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1807 - 1816
12345